Evidence map›Paper›PMID 28415572›Full record

ArticleOncotarget2017

Inhibition of iron overload-induced apoptosis and necrosis of bone marrow mesenchymal stem cells by melatonin.

Fan Yang, Yuan Li, Gege Yan, Tianyi Liu, Chao Feng, Rui Gong, Ye Yuan, Fengzhi Ding, Lai Zhang, Elina Idiiatullina and 11 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Iron metabolism in rheumatic diseases.Journal of translational autoimmunity · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 2 countries.

Fan YangDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Yuan LiDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Gege YanDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Tianyi LiuDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Chao FengDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Rui GongDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Ye YuanDepartment of Clinical Pharmacy, The Affiliated Second Hospital of Harbin Medical University, Harbin 150086, China.
Fengzhi DingDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Lai ZhangDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Elina IdiiatullinaCentral Laboratory of Scientific Research, Bashkir State Medical University, Ufa 450008, Russia.
Valentin PavlovCentral Laboratory of Scientific Research, Bashkir State Medical University, Ufa 450008, Russia.
Zhenbo HanDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Wenya MaDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Qi HuangDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Ying YuDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Zhengyi BaoDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Xiuxiu WangDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Bingjie HuaDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Zhimin DuDepartment of Clinical Pharmacy, The Affiliated Second Hospital of Harbin Medical University, Harbin 150086, China.
Benzhi CaiDepartment of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Lei YangDepartment of Orthopedics, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Harbin Medical University · CNBashkir State Medical University · RUSecond Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron overload induces severe damage to several vital organs such as the liver, heart and bone, and thus contributes to the dysfunction of these organs. The aim of this study is to investigate whether iron overload causes the apoptosis and necrosis of bone marrow mesenchymal stem cells (BMSCs) and melatonin may prevent its toxicity. Perls' Prussion blue staining showed that exposure to increased concentrations of ferric ammonium citrate (FAC) induced a gradual increase of intracellular iron level in BMSCs. Trypan blue staining demonstrated that FAC decreased the viability of BMSCs in a concentration-dependent manner. Notably, melatonin protected BMSCs against apoptosis and necrosis induced by FAC and it was vertified by Live/Dead, TUNEL and PI/Hoechst stainings. Furthermore, melatonin pretreatment suppressed FAC-induced reactive oxygen species accumulation. Western blot showed that exposure to FAC resulted in the decrease of anti-apoptotic protein Bcl-2 and the increase of pro-apoptotic protein Bax and Cleaved Caspase-3, and necrosis-related proteins RIP1 and RIP3, which were significantly inhibited by melatonin treatment. At last, melatonin receptor blocker luzindole failed to block the protection of BMSCs apoptosis and necrosis by melatonin. Taken together, melatonin protected BMSCs from iron overload induced apoptosis and necrosis by regulating Bcl-2, Bax, Cleaved Caspase-3, RIP1 and RIP3 pathways.

Indexed as

AnimalsApoptosisBone Marrow CellsCaspase 3Cell SurvivalDisease Models, AnimalFerric CompoundsIron OverloadMaleMelatoninMiceNecrosisOxidative StressProtective AgentsProto-Oncogene Proteins c-bcl-2Quaternary Ammonium CompoundsCaspase 3ferric ammonium citrateFerric CompoundsMelatoninProtective AgentsProto-Oncogene Proteins c-bcl-2Quaternary Ammonium CompoundsReactive Oxygen Speciesapoptosisbone marrow mesenchymal stem cellsiron overloadmelatoninnecrosis

Identifiers

PMID28415572
PMCPMC5458235
OpenAlexW2595943654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.